The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2025

Filed:

Aug. 19, 2022
Applicant:

Life Technologies Corporation, Carlsbad, CA (US);

Inventors:

Zhiwei Yang, San Diego, CA (US);

Parul Angrish, San Diego, CA (US);

Xavier De Mollerat Du Jeu, Encinitas, CA (US);

Kristin Wiederholt, Vista, CA (US);

Assignee:

Life Technologies Corporation, Carlsbad, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/54 (2017.01); A61K 48/00 (2006.01); C07C 227/06 (2006.01); C07C 229/08 (2006.01); C07D 211/28 (2006.01); C07D 211/58 (2006.01); C12N 15/113 (2010.01); C12N 15/88 (2006.01);
U.S. Cl.
CPC ...
A61K 47/54 (2017.08); A61K 47/543 (2017.08); A61K 48/0008 (2013.01); C07C 227/06 (2013.01); C07C 229/08 (2013.01); C07D 211/28 (2013.01); C07D 211/58 (2013.01); C12N 15/1137 (2013.01); C12N 15/88 (2013.01); C12N 2310/11 (2013.01); C12N 2310/141 (2013.01);
Abstract

There are provided for herein novel amine-containing transfection compounds and methods for making and using same. The compounds are generally obtained by reacting a primary amine with an unsaturated compound. Transfection complexes made using the amine-containing transfection compounds in combination with additional compounds to encapsulate biologically active agents such as nucleic acids are also provided for herein. Methods of using the transfection complexes for the in vivo or in vitro delivery of biologically active agents are also described. The transfection complexes of the present invention are highly potent, thereby allowing effective modulation of a biological activity at relatively low doses compared to analogous transfection compounds known in the art.


Find Patent Forward Citations

Loading…